Amgen Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Amgen Inc (AMGN) has a 3-month relative strength percentile of 43 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.5%, relative volume 1.15×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
43 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
AMGN is held by 24 ETFs as of Mar 2026. Top owner: VTI at 0.30% weight, $6.0B notional. Top 3 carry $14.8B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.30% | $6.0B |
| VOOVanguard S&P 500 ETF | 0.34% | $4.8B |
| QQQInvesco QQQ Trust Series I | 1.07% | $4.0B |
| IVViShares Core S&P 500 ETF | 0.34% | $2.4B |
| SPYState Street SPDR S&P 500 ETF | 0.34% | $2.2B |
| VTVVanguard Value ETF | 0.78% | $1.8B |
| XLVState Street Health Care Select Sector SPDR ETF | 3.57% | $1.4B |
| IWFiShares Russell 1000 Growth ETF | 0.50% | $563M |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 0.34% | $398M |
| IVWiShares S&P 500 Growth ETF | 0.44% | $271M |
Showing 10 of 24 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AMGN Jan avg: 4.79% median: 6.78% win: 75% σ: 6.23% n: 4 2022-04-12 → 2026-05-29 | AMGN Feb avg: 0.10% median: -0.14% win: 50% σ: 12.64% n: 4 2022-04-12 → 2026-05-29 | AMGN Mar avg: -0.01% median: 2.48% win: 75% σ: 6.39% n: 4 2022-04-12 → 2026-05-29 | AMGN Apr avg: -3.95% median: -3.65% win: 0% σ: 2.83% n: 5 2022-04-12 → 2026-05-29 | AMGN May avg: 2.02% median: -0.94% win: 40% σ: 8.50% n: 5 2022-04-12 → 2026-05-29 | AMGN Jun avg: -1.39% median: -1.25% win: 50% σ: 3.38% n: 4 2022-04-12 → 2026-05-29 (current) | AMGN Jul avg: 4.82% median: 5.58% win: 100% σ: 2.11% n: 4 2022-04-12 → 2026-05-29 | AMGN Aug avg: 1.12% median: -1.05% win: 50% σ: 5.76% n: 4 2022-04-12 → 2026-05-29 | AMGN Sep avg: -1.69% median: -2.70% win: 25% σ: 4.70% n: 4 2022-04-12 → 2026-05-29 | AMGN Oct avg: 5.05% median: 2.56% win: 50% σ: 10.84% n: 4 2022-04-12 → 2026-05-29 | AMGN Nov avg: 3.88% median: 5.69% win: 75% σ: 11.39% n: 4 2022-04-12 → 2026-05-29 | AMGN Dec avg: -3.65% median: -6.56% win: 25% σ: 7.10% n: 4 2022-04-12 → 2026-05-29 |